Publications and Presentations
04/07/21 – Newsletter
Roger N. Morris New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing Health and Life Sciences Roger N. Morris, Edward D. Rickert, William (Bill) J. Toman, Richard B. DavisOn March 26, 2021, Wisconsin enacted 2021 Wisconsin Act 9 (the "Act"), which, among other items, requires a pharmacy benefit manager ("PBM") to obtain licensure from the Office of the Commissioner of Insurance ("OCI"). The Act passed overwhelmingly via rare... Read More
04/06/21 – Article
"To Be or Not to 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback" Pratt's Government Contracting Law Report By: Brenda M. Maloney Shafer, Richard B. Davis, David M. Blank
01/05/21 – Blog
The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback To Be Or Not To 340B Brenda M. Maloney Shafer, Richard B. Davis, David M. Blank
12/02/20 – Newsletter
New Wisconsin Patient Consultation Rule Affecting Resident and Non-Resident Pharmacies to Take Effect on January 1, 2021 Health & Life Sciences Alert Susan Brichler Trujillo, Richard B. Davis, Christopher M. Guthrie
09/30/20 – Article
"Drug Manufacturers Cut Off 340B Pricing for Contract Pharmacies" State Bar of Wisconsin's Health Law Blog Richard B. Davis
08/20/20 – Newsletter
AstraZeneca to Cut Off 340B Pricing for Contract Pharmacies on October 1 Health & Life Sciences Alert Brenda M. Maloney Shafer, Richard B. Davis
07/10/20 – Newsletter
Notice to Covered Entities: Manufacturer Seeking 340B Claims Data To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis
05/20/20 – Presentation
"Multistate Pharmacy Jurisprudence Review" Medical College of Wisconsin School of Pharmacy By: Roger N. Morris, Richard B. Davis
04/30/20 – Newsletter
CMS Publishes 340B Drug Acquisition Cost Survey: Respond by May 15, 2020 To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis
03/23/20 – Newsletter
HRSA Unveils New 340B Flexibilities During COVID-19 Crisis To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis
02/03/20 – Newsletter
GAO Report Suggests Increased Oversight of 340B Program To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis
01/14/20 – Newsletter
The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies: Board Submits Final Rule Draft Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis, Christopher M. Guthrie
11/25/19 – Newsletter
Board’s Economic Impact Analysis Disputes Industry Submissions, Board Advances Proposed Rule Without Changes Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis
11/19/19 – Newsletter
Results of Economic Impact Discussion: The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis
11/05/19 – Newsletter
The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies: Potential Relief for Mail Order Pharmacies? Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis
10/30/19 – Newsletter
The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis
10/25/19 – Newsletter
Update on Status of Proposed Wisconsin Patient Counseling Rule that Will Impact Mail Order Pharmacies Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis
10/14/19 – Newsletter
Applications Now Available for Alaska's New Licensing Categories and Prescription Standards Health & Life Sciences Alert Susan B. Trujillo, Nicholas H. Meza, Richard B. Davis
09/18/19 – Newsletter
New PBM State Laws Indicate a Shifting Battlefront over 340B Program Drug Pricing To Be or to Not to 340B Blog Brenda M. Shafer, Richard B. Davis
08/06/19 – Newsletter
Interesting 340B Takeaways from 2020 OPPS Proposed Rule To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis, Benjamin A. Lockwood
08/01/19 – Newsletter
503B Loses Federal Preemption Argument, Appeals to Ninth Circuit Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis, Benjamin A. Lockwood
07/18/19
"The 340B Drug Pricing Program Year in Review: What's Smoke and What's Fire in a Changing Landscape" Quarles & Brady Pharmacy Law Symposium
07/09/19 – Blog
340B Litigation Updates and Other Program Developments To Be or Not to 340B Brenda M. Shafer, Richard B. Davis
03/19/19 – Newsletter
The President’s 2020 Budget Keeps 340B Program in the Spotlight To Be or Not to 340B Brenda Maloney Shafer, Richard Davis
02/25/19 – Blog
"CVS Caremark Reverses Planned Payment Cuts to 340B Providers" To Be or Not to 340B Brenda M. Shafer, Richard B. Davis
01/29/19 – Blog
"We're 340Back! Review of Major Developments to the 340B Program" To Be or Not to 340B Brenda M. Shafer and Richard B. Davis
Roger N. Morris
